Molekulare Pharmakologie und Toxikologie: biologische Grundlagen von Arzneimitteln und Giften
Saved in:
Main Author: | |
---|---|
Format: | Book |
Language: | German |
Published: |
Berlin [u.a.]
Springer
2006
|
Series: | Springer-Lehrbuch
|
Subjects: | |
Links: | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=014572359&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
Item Description: | Literaturverz. S. [297] - 312 |
Physical Description: | X, 328 S. Ill., graph. Darst. 24 cm |
ISBN: | 354021223X 9783540212232 |
Staff View
MARC
LEADER | 00000nam a2200000 c 4500 | ||
---|---|---|---|
001 | BV021250954 | ||
003 | DE-604 | ||
005 | 20220112 | ||
007 | t| | ||
008 | 051202s2006 gw ad|| |||| 00||| ger d | ||
016 | 7 | |a 971621888 |2 DE-101 | |
020 | |a 354021223X |9 3-540-21223-X | ||
020 | |a 9783540212232 |9 978-3-540-21223-2 | ||
035 | |a (OCoLC)180080757 | ||
035 | |a (DE-599)BVBBV021250954 | ||
040 | |a DE-604 |b ger |e rakddb | ||
041 | 0 | |a ger | |
044 | |a gw |c XA-DE-BE | ||
049 | |a DE-91 |a DE-20 |a DE-355 |a DE-29 |a DE-19 |a DE-210 |a DE-526 |a DE-11 |a DE-70 |a DE-1029 | ||
082 | 0 | |a 610 | |
084 | |a VS 5401 |0 (DE-625)147690:254 |2 rvk | ||
084 | |a VT 5010 |0 (DE-625)147739: |2 rvk | ||
084 | |a VW 5010 |0 (DE-625)147760: |2 rvk | ||
084 | |a WG 7400 |0 (DE-625)148616: |2 rvk | ||
084 | |a XI 1200 |0 (DE-625)152971: |2 rvk | ||
084 | |a XI 1800 |0 (DE-625)152978:12905 |2 rvk | ||
084 | |a MED 950f |2 stub | ||
084 | |a CHE 800f |2 stub | ||
084 | |a BIO 180f |2 stub | ||
084 | |a 610 |2 sdnb | ||
100 | 1 | |a Efferth, Thomas |d 1960- |e Verfasser |0 (DE-588)112533116 |4 aut | |
245 | 1 | 0 | |a Molekulare Pharmakologie und Toxikologie |b biologische Grundlagen von Arzneimitteln und Giften |c Thomas Efferth |
264 | 1 | |a Berlin [u.a.] |b Springer |c 2006 | |
300 | |a X, 328 S. |b Ill., graph. Darst. |c 24 cm | ||
336 | |b txt |2 rdacontent | ||
337 | |b n |2 rdamedia | ||
338 | |b nc |2 rdacarrier | ||
490 | 0 | |a Springer-Lehrbuch | |
500 | |a Literaturverz. S. [297] - 312 | ||
650 | 0 | 7 | |a Molekularpharmakologie |0 (DE-588)4170397-2 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Molekulare Medizin |0 (DE-588)4543844-4 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Toxikologie |0 (DE-588)4060538-3 |2 gnd |9 rswk-swf |
689 | 0 | 0 | |a Molekularpharmakologie |0 (DE-588)4170397-2 |D s |
689 | 0 | |5 DE-604 | |
689 | 1 | 0 | |a Toxikologie |0 (DE-588)4060538-3 |D s |
689 | 1 | 1 | |a Molekulare Medizin |0 (DE-588)4543844-4 |D s |
689 | 1 | |5 DE-604 | |
856 | 4 | 2 | |m Digitalisierung UB Regensburg |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=014572359&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
943 | 1 | |a oai:aleph.bib-bvb.de:BVB01-014572359 |
Record in the Search Index
DE-BY-TUM_call_number | 2502 BIO 180 2006 A 9234 |
---|---|
DE-BY-TUM_katkey | 1532991 |
DE-BY-TUM_location | 25 |
DE-BY-TUM_media_number | 040006259114 |
_version_ | 1821932888664309760 |
adam_text | Inhaltsverzeichnis
1 Grundlagen der Pharmakologie und Toxikologie..........................1
1.1 Pharmakokinetik......................................................................1
1.1.1 Resorption..................................................................1
1.1.2 Distribution................................................................4
1.1.3 Biotransformation.......................................................5
1.1.4 Eliminierung...............................................................7
1.2 Pharmakodynamik...................................................................7
1.3 Rezeptoren und Ionenkanäle.................................................10
1.4 Signaltransduktion.................................................................13
1.5 Unerwünschte Wirkungen.....................................................15
1.6 Arzneimittel-Interaktionen....................................................16
2 Molekulare Mechanismen der Pharmakokinetik.......................19
2.1 Einleitung..............................................................................19
2.2 Phase
2.2.1 Grundlagen...............................................................20
2.2.2 Cytochrom-^SO-Monooxygenasen,
Familie CYP1...........................................................21
2.2.3 Cytochrom^SO-Monooxigenasen,
Familie CYP2...........................................................22
2.2.4 Cytochrom-P450-Monooxigenasen,
Familie CYP3...........................................................23
2.2.5 Cytochrom^SO-Monooxigenasen,
Familie CYP4...........................................................24
2.2.6 Arylkohlenwasserstoff-Rezeptor..............................25
2.3 Phasell..................................................................................28
2.3.1 Glutathion-S-Transf
2.3.2 UDP-Glucuronyltransferasen...................................30
2.3.3 Sulfotransferasen......................................................33
2.3.4 JV-Acetyltransferasen................................................35
2.3.5 Catechol-O-Methyltransferase.................................36
VIII Inhaltsverzeichnis
2.4 Phase
2.4.1 ATP-bindende Kassetten (ABC)-Transporter..........40
2.4.2 Organische Anionen-Transporter.............................45
2.4.3 Organische Kationen-Transporter............................47
Wirkprinzipien klassischer Medikamente...................................51
3.1 Vegetatives Nervensystem....................................................51
3.1.1
3.1.2 Grundlagen...............................................................52
3.1.3 Sympathisches Nervensystem..................................54
3.1.4 Parasympathisches Nervensystem............................56
3.2 Glatte Muskulatur..................................................................57
3.3 Motorisches System...............................................................59
3.4 Herz.......................................................................................61
3.5 Gehirn....................................................................................62
3.6 Schmerztherapie....................................................................64
3.7 Hormone und Mediatorsubstanzen........................................66
3.8 Blut........................................................................................71
3.9 Gastrointestinaltrakt...............................................................73
3.10 Niere......................................................................................75
3.11 Infektionen.............................................................................75
3.11.1 Antibakterielle Wirkstoffe........................................75
3.11.2 Antimykotische Wirkstoffe......................................78
3.11.3 Antimalaria-Wirkstoffe............................................78
3.11.4
3.12 Tumorerkrankungen..............................................................80
Entwicklung neuer Medikamente................................................85
4.1 Einleitung..............................................................................85
4.2 Kombinatorische Chemie......................................................86
4.3 Naturstoffe.............................................................................88
4.4 Therapeutische Proteine und
4.5 Strategien der Chemogenomik..............................................89
4.6 Pharmazeutische Technologie (Galenik)...............................94
4.7 Klinische Prüfung..................................................................98
Molekulare zielgerichtete Therapieformen...............................101
5.1 Einleitung............................................................................101
5.2 Proteine als Zielmoleküle....................................................102
5.2.1 Antikörpertherapie.................................................102
5.2.2 Vakzine.........................................................112
Inhaltsverzeichnis
5.3
5.3.1
5.3.2 Ribozyme...............................................................122
5.3.3 RNA-Interferenz..................................................... 126
5.4 Gentherapie.......................................................................... 131
5.4.1 Einleitung...............................................................131
5.4.2 Retrovirale Gentherapie......................................... 133
5.4.3 Adenovirale Gentherapie........................................ 136
5.4.4 Weitere
5.4.5
5.5 Stammzell-Therapie............................................................. 144
5.5.1 Einleitung...............................................................144
5.5.2 Embryonale Stammzellen...................................... 144
5.5.3
5.5.4 Anwendungsmöglichkeiten....................................147
Molekulare Toxikologie...............................................................153
6.1 Genotoxizität, Mutagenese und DNA-Reparatur................ 153
6.1.1 DNA-Schäden und DNA-Mutationen....................153
6.1.2 Oxidativer und nitrosativer
6.1.3 DNA-Reparatur......................................................161
6.1.4 Zellzyklus-Progression und -Kontrolle.................. 170
6.1.5 DNA-Schadenstoleranz..........................................175
6.1.6 Erkennung von DNA-Schäden
durch Chromatin-Proteine......................................178
6.1.7 Schädigung und Reparatur von
und Proteinen......................................................... 180
6.2 Kanzerogenese..................................................................... 182
6.2.1 Mehrschritt-Kanzerogenese...................................183
6.2.2 Mutator-Phänotyp...................................................187
6.2.3 Chromosomale Instabilität..................................... 189
6.2.4 Onkogene und Tumorsuppressor-Gene..................194
6.2.5 Apoptose................................................................199
6.2.6 Zelluläre Seneszenz................................................205
6.2.7 Chromosomen-Segregation und Aneuploidie........206
6.2.8 Invasion und Metastasierung..................................208
6.2.9 Neoangiogenese.....................................................219
6.2.10 Epigenetik..............................................................223
6.2.11 Chemoprävention................................................... 226
6.3 Teratogenität........................................................................228
6.4 Reproduktive und endokrine Toxizität................................230
6.5 Hepatotoxizität.....................................................................233
X
6.6 Nephrotoxizität....................................................................235
6.7 Kardiotoxizität.....................................................................238
6.7.1 Myokardiale Reaktionen auf toxischen
6.7.2 Molekulare Mechanismen der Kardiotoxizität.......240
6.7.3 Beispiele kardiotoxisch wirkender Substanzen......241
6.8 Neurotoxizität......................................................................242
6.8.1 Blut-Hirn-Schranke................................................242
6.8.2 Toxizität im zentralen Nervensystem.....................243
6.8.3 Molekulare Mechanismen der ZNS-Toxizität........244
6.8.4 Beispiele neurotoxischer ZNS-Gifte......................245
6.8.5 Toxizität im peripheren Nervensystem..................246
6.9 Hauttoxizität........................................................................247
6.10 Lungentoxizität....................................................................249
6.10.1 Anthropogene und
in der Luft...............................................................249
6.10.2 Rauchen und Krebs................................................252
6.11 Knochenmark-Toxizität.......................................................253
6.12 Immuntoxizität.....................................................................255
7 Prädiktive Pharmakologie und Toxikologie:
Genetik, Genomik, Systembiologie.............................................261
7.1 Pharmako- und Toxikogenetik............................................261
7.1.1 Grundlagen.............................................................261
7.1.2 Polymorphismen in Rezeptorgenen........................264
7.1.3 Polymorphismen in Phase I-Enzymen...................270
7.1.4 Polymorphismen in Phase-II-Enzymen..................274
7.1.5 Polymorphismus in anderen Enzymen...................276
7.1.6 Polymorphismen in Transportergenen...................279
7.1.7 Polymorphismen in DNA-Reparaturgenen............281
7.1.8 Perspektiven und klinische
Entscheidungsfindung............................................283
7.2 Pharmako- und Toxikogenomik..........................................285
7.2.1 Einleitung...............................................................285
7.2.2 Genomik.................................................................285
7.2.3 Proteomik...............................................................288
7.2.4 Metabonomik.........................................................292
7.2.5 Bioinformatik.........................................................292
7.3 Systembiologie....................................................................294
Literatur.................................................................................................297
Sachverzeichnis.....................................................................................313
|
any_adam_object | 1 |
author | Efferth, Thomas 1960- |
author_GND | (DE-588)112533116 |
author_facet | Efferth, Thomas 1960- |
author_role | aut |
author_sort | Efferth, Thomas 1960- |
author_variant | t e te |
building | Verbundindex |
bvnumber | BV021250954 |
classification_rvk | VS 5401 VT 5010 VW 5010 WG 7400 XI 1200 XI 1800 |
classification_tum | MED 950f CHE 800f BIO 180f |
ctrlnum | (OCoLC)180080757 (DE-599)BVBBV021250954 |
dewey-full | 610 |
dewey-hundreds | 600 - Technology (Applied sciences) |
dewey-ones | 610 - Medicine and health |
dewey-raw | 610 |
dewey-search | 610 |
dewey-sort | 3610 |
dewey-tens | 610 - Medicine and health |
discipline | Chemie / Pharmazie Biologie Medizin |
format | Book |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02159nam a2200553 c 4500</leader><controlfield tag="001">BV021250954</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20220112 </controlfield><controlfield tag="007">t|</controlfield><controlfield tag="008">051202s2006 gw ad|| |||| 00||| ger d</controlfield><datafield tag="016" ind1="7" ind2=" "><subfield code="a">971621888</subfield><subfield code="2">DE-101</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">354021223X</subfield><subfield code="9">3-540-21223-X</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9783540212232</subfield><subfield code="9">978-3-540-21223-2</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)180080757</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV021250954</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">ger</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">gw</subfield><subfield code="c">XA-DE-BE</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-91</subfield><subfield code="a">DE-20</subfield><subfield code="a">DE-355</subfield><subfield code="a">DE-29</subfield><subfield code="a">DE-19</subfield><subfield code="a">DE-210</subfield><subfield code="a">DE-526</subfield><subfield code="a">DE-11</subfield><subfield code="a">DE-70</subfield><subfield code="a">DE-1029</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">VS 5401</subfield><subfield code="0">(DE-625)147690:254</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">VT 5010</subfield><subfield code="0">(DE-625)147739:</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">VW 5010</subfield><subfield code="0">(DE-625)147760:</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">WG 7400</subfield><subfield code="0">(DE-625)148616:</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">XI 1200</subfield><subfield code="0">(DE-625)152971:</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">XI 1800</subfield><subfield code="0">(DE-625)152978:12905</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">MED 950f</subfield><subfield code="2">stub</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">CHE 800f</subfield><subfield code="2">stub</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">BIO 180f</subfield><subfield code="2">stub</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">610</subfield><subfield code="2">sdnb</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Efferth, Thomas</subfield><subfield code="d">1960-</subfield><subfield code="e">Verfasser</subfield><subfield code="0">(DE-588)112533116</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Molekulare Pharmakologie und Toxikologie</subfield><subfield code="b">biologische Grundlagen von Arzneimitteln und Giften</subfield><subfield code="c">Thomas Efferth</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Berlin [u.a.]</subfield><subfield code="b">Springer</subfield><subfield code="c">2006</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">X, 328 S.</subfield><subfield code="b">Ill., graph. Darst.</subfield><subfield code="c">24 cm</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Springer-Lehrbuch</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Literaturverz. S. [297] - 312</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Molekularpharmakologie</subfield><subfield code="0">(DE-588)4170397-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Molekulare Medizin</subfield><subfield code="0">(DE-588)4543844-4</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Toxikologie</subfield><subfield code="0">(DE-588)4060538-3</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Molekularpharmakologie</subfield><subfield code="0">(DE-588)4170397-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Toxikologie</subfield><subfield code="0">(DE-588)4060538-3</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Molekulare Medizin</subfield><subfield code="0">(DE-588)4543844-4</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">Digitalisierung UB Regensburg</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=014572359&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="943" ind1="1" ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-014572359</subfield></datafield></record></collection> |
id | DE-604.BV021250954 |
illustrated | Illustrated |
indexdate | 2024-12-20T12:31:34Z |
institution | BVB |
isbn | 354021223X 9783540212232 |
language | German |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-014572359 |
oclc_num | 180080757 |
open_access_boolean | |
owner | DE-91 DE-BY-TUM DE-20 DE-355 DE-BY-UBR DE-29 DE-19 DE-BY-UBM DE-210 DE-526 DE-11 DE-70 DE-1029 |
owner_facet | DE-91 DE-BY-TUM DE-20 DE-355 DE-BY-UBR DE-29 DE-19 DE-BY-UBM DE-210 DE-526 DE-11 DE-70 DE-1029 |
physical | X, 328 S. Ill., graph. Darst. 24 cm |
publishDate | 2006 |
publishDateSearch | 2006 |
publishDateSort | 2006 |
publisher | Springer |
record_format | marc |
series2 | Springer-Lehrbuch |
spellingShingle | Efferth, Thomas 1960- Molekulare Pharmakologie und Toxikologie biologische Grundlagen von Arzneimitteln und Giften Molekularpharmakologie (DE-588)4170397-2 gnd Molekulare Medizin (DE-588)4543844-4 gnd Toxikologie (DE-588)4060538-3 gnd |
subject_GND | (DE-588)4170397-2 (DE-588)4543844-4 (DE-588)4060538-3 |
title | Molekulare Pharmakologie und Toxikologie biologische Grundlagen von Arzneimitteln und Giften |
title_auth | Molekulare Pharmakologie und Toxikologie biologische Grundlagen von Arzneimitteln und Giften |
title_exact_search | Molekulare Pharmakologie und Toxikologie biologische Grundlagen von Arzneimitteln und Giften |
title_full | Molekulare Pharmakologie und Toxikologie biologische Grundlagen von Arzneimitteln und Giften Thomas Efferth |
title_fullStr | Molekulare Pharmakologie und Toxikologie biologische Grundlagen von Arzneimitteln und Giften Thomas Efferth |
title_full_unstemmed | Molekulare Pharmakologie und Toxikologie biologische Grundlagen von Arzneimitteln und Giften Thomas Efferth |
title_short | Molekulare Pharmakologie und Toxikologie |
title_sort | molekulare pharmakologie und toxikologie biologische grundlagen von arzneimitteln und giften |
title_sub | biologische Grundlagen von Arzneimitteln und Giften |
topic | Molekularpharmakologie (DE-588)4170397-2 gnd Molekulare Medizin (DE-588)4543844-4 gnd Toxikologie (DE-588)4060538-3 gnd |
topic_facet | Molekularpharmakologie Molekulare Medizin Toxikologie |
url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=014572359&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
work_keys_str_mv | AT efferththomas molekularepharmakologieundtoxikologiebiologischegrundlagenvonarzneimittelnundgiften |
Table of Contents
Order paper/chapter scan
Order paper/chapter scan
Branch Library Sport & Health Sciences
Call Number: |
2502 BIO 180 2006 A 9234
Floor plan |
---|---|
Copy 1 | Available for loan On Shelf |